EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Athenex's Enterprise Value is $11.0 Mil.
Athenex's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-73.7 Mil. Therefore, Athenex's EV-to-EBIT for today is -0.15.
The historical rank and industry rank for Athenex's EV-to-EBIT or its related term are showing as below:
ATNXQ's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.115 * Ranked among companies with meaningful EV-to-EBIT only.
The historical data trend for Athenex's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Athenex's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athenex's EV-to-EBIT Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Athenex's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Athenex's EV-to-EBIT falls into.
Athenex's current Enterprise Value is $11.0 Mil.
Athenex's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-73.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Athenex (OTCPK:ATNXQ) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Athenex's Enterprise Value for the quarter that ended in Dec. 2022 was $18.6 Mil.
Athenex's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-73.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Athenex EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Athenex's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting preclinical and clinical testing, recruiting personnel, identifying and evaluating additional drug candidates for potential in-licensing or acquisition, and raising capital to support development and commercialization activities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATNXQ has been successfully added to your 